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Abstract
The present study examined the underlying mechanisms by which whey protein isolate (WPI) affects energy balance. C57BL/6J mice were
fed a diet containing 10 % energy from fat, 70 % energy from carbohydrate (35 % energy from sucrose) and 20 % energy from casein or WPI
for 15 weeks. Mice fed with WPI had reduced weight gain, cumulative energy intake and dark-phase VO2 compared with casein-fed mice
(P,0·05); however, WPI intake had no significant effects on body composition, meal size/number, water intake or RER. Plasma levels of
insulin, TAG, leptin, glucose and glucagon-like peptide 1 remained unchanged. Notably, the intake of WPI reduced stomach weight and
both length and weight of the small intestine (P,0·05). WPI intake reduced the gastric expression of Wingless/int-1 5a (Wnt5a) (P,0·01)
and frizzled 4 (Fzd4) (P,0·01), with no change in the expression of receptor tyrosine kinase-like orphan receptor 2 (Ror2) and LDL
receptor-related protein 5 (Lrp5). In the ileum, WPI increased the mRNA expression of Wnt5a (P,0·01) and caused a trend towards an
increase in the expression of Fzd4 (P¼0·094), with no change in the expression of Ror2 and Lrp5. These genes were unresponsive in
the duodenum. Among the nutrient-responsive genes, WPI specifically reduced ileal mRNA expression of peptide YY (P,0·01) and
fatty acid transporter protein 4 (P,0·05), and decreased duodenal mRNA expression of the insulin receptor (P¼0·05), with a trend towards
a decreased expression of Na–glucose co-transporter 1 (P¼0·07). The effects of WPI on gastrointestinal Wnt signalling may explain how
this protein affects gastrointestinal structure and function and, in turn, energy intake and balance.
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Whey proteins are a by-product of cheese manufacturing. In
recent years, these dietary proteins have gained considerable
interest in relation to their health benefits, including reduction
in energy intake and body weight, and improvement in insulin
sensitivity(1,2). However, more research is required to assess
whether the effects of whey protein are dependent on macro-
nutrient composition in the diet, as demonstrated previously
for diets enriched with whey protein(3), as this will allow
the formulation of diets with the optimum macronutrient
combination that confers specific beneficial effects on human
health. Furthermore, such analysis may also reveal the mechan-
isms underpinning the effects of these proteins.
We have previously shown that intake of 20 % energy from
whey protein isolate (WPI) reduces weight gain and fat mass,
and increases lean mass in mice fed a high-fat (45 % energy)
diet(4,5). In contrast, intake of a high whey protein content
(above the 14–25 % adequate energy range) has been
shown to influence energy balance in mice fed a low-fat
diet (10 % energy from fat). Moreover, where an effect is
found, the underlying mechanisms have not been elucidated.
For instance, mice fed a diet containing 30 % energy from
whey protein and 10 % energy from fat exhibited reduced
energy intake and weight gain by 1 week compared with
mice fed a similar diet but with either soya or gluten as the
protein source(6). A reduction in cumulative energy intake
was observed in rats fed a diet containing 42 % energy from
protein (26 % whey and 16 % albumin) between 5 and
10 weeks compared with those fed a similar diet but whey
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replaced by either albumin or soya protein(7). In contrast,
when energy from dietary protein was reduced to 15 or
25 %, with energy from fat being maintained at about 9 and
15 %, respectively, whey protein did not affect energy intake
and body-weight gain(8,9). Interestingly, the latter studies
assessed food intake only for a period of 2 or 7 weeks, in
comparison to the study on high whey protein, in which the
reduction in energy intake occurred by week 5 and continued
up to 10 weeks(7). Thus, this discrepancy in the data could be
attributed to the test duration, where a longer duration is
required when an adequate proportion of energy derived
from protein is used in test diets. Thus, the purpose of the
present study was to assess whether WPI at 20 % energy in a
diet containing 10 % energy from fat alters energy balance
and, where there is an effect, to explore the underlying
mechanisms. The study lasted for 15 weeks in consideration
of the previous published data showing that whey protein
(at an adequate range) did not affect energy balance up to
7 weeks(8,9).
Materials and methods
Animals and diets
All procedures involving animals were approved by the
University College Cork Animal Experimentation Ethics
Committee (2011/005) and were licensed under the Cruelty to
Animals Act 1876. Male C57BL/6J mice (Harlan), aged 3 weeks
old, were singly housed and had ad libitum access to food and
water throughout the trial.Micewere initially fed adiet containing
10% energy from fat and 35% energy from sucrose with 20%
energy from casein (LF-CAS, #D12450; Research Diets) during
the acclimatisation period lasting for 3 weeks.
Experimental protocol
Following acclimatisation, singly housed mice were separated
into two weight-matched dietary groups (n 8 animals per
group) and provided with either the LF-CAS diet or a similar
diet containing 10 % energy from fat and 35 % energy from
sucrose with 20 % energy from whey protein isolate
(LF-WPI, AlacenTM 895; NZMP) for a total of 15 weeks. Further
details of the diet composition can be found in online
Supplementary Table S1. Body weight and energy intake
were measured weekly. In addition, at week 14, feeding
behaviour and metabolic activity were measured using the
TSE PhenoMaster System (TSE Systems GmbH) comprising
eight test cages and one reference cage. Mice were housed indi-
vidually in the test cages. After a 2 d acclimatisation period,
metabolic parameters were measured on the 3rd day. Sensors
recorded metabolic parameters in the cages sequentially, with
each cage being analysed for 1 min, such that data collected
over a 24 h period corresponded to intervals of 9 min for the
eight test cages and one reference cage. Body composition
was determined by NMR using a Bruker Minispec LF50H
(Bruker Optics) at the end of the study, following a 6–8 h
fast. Subsequently, mice were anaesthetised and blood was
collected. Mice were then killed by cervical dislocation.
Tissues of interest were excised and weighed. Small-intestinal
luminal contents were removed by mechanical expulsion and
tissue length was determined. Tissue was weighed, and 2 cm
sections from the proximal and distal parts of the intestine
that were 2 cm away from the start and end of the intestine,
respectively, were excised for the analysis of gene expression
in the duodenum and ileum. All tissues were immediately
snap-frozen in liquid N2. Plasma and tissue samples were
stored at 2808C until analysis.
Biochemical analysis
Blood collected into EDTA-containing vacutainer tubes (BD)
from anaesthetised mice (ketamine, 65 mg/kg and xylazine,
13 mg/kg) was treated with diprotin A and aprotinin, as
described previously(4), to protect plasma peptides against pro-
teolytic degradation. Plasma was isolated by centrifugation at
2000 rpm for 15 min at 48C, and plasma concentrations of glu-
cose (Calbiochem) and TAG (LabAssay TAG; Wako Chemicals)
were analysed using colorimetric assay kits. ELISA kits were
used to determine plasma concentrations of glucagon-like
peptide 1 (GLP-1; Millipore), leptin and insulin (Crystal
Chem). Homeostasis model assessment of insulin resistance
was calculated as described previously(4).
Tissue gene expression
Total RNA was isolated from tissues of interest (epididymal
adipose tissue, liver, skeletal muscle, duodenum and ileum)
using RNeasy mini kits (Qiagen) with subsequent DNase
treatment to prevent genomic DNA contamination. Duodenal
and ileal total RNA was isolated from representative intact
tissue segments. Complementary DNA was synthesised
from 1mg of isolated total RNA and subjected to real-time
quantitative PCR analysis, as described previously(4). Primer
sequences of target and reference genes are listed in online
Supplementary Table S2. The mRNA expression of target
genes was calculated by the 22DDCp (crossing point)
method, after normalising against the expression of the refer-
ence gene according to the following formula:
DDCp ¼ DCp ðtarget geneÞ2 DCp ðreference geneÞ:
b-Actin (adipose, liver, muscle, duodenum and ileum), tyrosine
3-monooxygenase/tryptophan 5-monooxygenase activation
protein, zeta polypeptide (YWHAZ) (liver, duodenum and
ileum) and 18S (adipose) were used as the reference genes.
In instances where two housekeeping genes were used, a
geometric mean was determined for normalisation. Gene
expression is shown relative to the LF-CAS group.
Statistical analysis
Data are presented as means with their standard errors. The
effects of dietary treatments were analysed by unpaired
t tests. A two-way repeated-measures ANOVA with Bonferroni’s
multiple comparisons was used to analyse body-weight
trajectories over the treatment periods. Mann–Whitney U tests
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were used to analyse non-parametric data. VO2 data were
analysed by ANCOVA (SAS software version 9.3), with total
body weight being used as the covariant, as described
previously(10). Significance was set at P#0·05, using GraphPad
Prism (version 6; GraphPad Software Inc.), SAS software
(version 9.3; SAS Institute Inc.) and Minitab (version 15;
Minitab Ltd).
Results
Effect whey protein isolate on weight gain and
body composition
Cumulative energy intake was significantly reduced in the
LF-WPI group over the first 13 weeks, and this significance
was observed from week 11 onwards (P,0·05; Fig. 1(d)).
In contrast, body-weight gain was not significantly different
at week 11 (6·17 (SE 0·28) g for the LF-WPI group v. 7·05
(SE 0·54) g for the LF-CAS group; P¼0·17), but reached signifi-
cance by week 12 (5·89 (SE 0·24) g for the LF-WPI group v. 7·5
(SE 0·61) g for the LF-CAS group; P,0·05). Although after
15 weeks of dietary treatments, total body-weight gain was
significantly reduced in the LF-WPI group compared with the
LF-CAS group (P,0·05; Fig. 1(b)), there was no significant
difference observed in either body weight or body composition
(percentage of fat or lean mass) between the two groups
(Fig. 1(a) and (c), respectively). Consistent with the overall per-
centage of body fat mass, the mass of both subcutaneous and
epididymal adipose tissue depots was not significantly different
between the LF-CAS and LF-WPI groups (Fig. 2(a)).
Effect of whey protein isolate on energy intake and
metabolic parameters
A further analysis of energy intake using the TSE PhenoMaster
cages in week 14 (Table 1) showed a reduction of energy
intake during the dark phase in the LF-WPI group, although
this was not significant. Also, no significant effects were
observed for the 24 h meal pattern, represented by meal
number and size, RER, and water intake; however, there was
a reduction in VO2 during the dark phase in the LF-WPI
group and also a trend towards a decrease in VO2 during the
light phase (Table 1), as revealed by the analysis of metabolic
data independent of the body weights of mice.
Effect of whey protein isolate on the gastrointestinal tract
The LF-WPI group had reduced stomach and small-intestinal
weights relative to the LF-CAS group after 15 weeks of dietary
treatments, which also corresponded with a concomitant
reduction in small-intestinal length (Fig. 2).
At the cellular level, WPI intake reduced the gene
expression of Wingless/int-1 5a (Wnt5a) and frizzled 4
(Fzd4) in the stomach, but not the expression of receptor
tyrosine kinase-like orphan receptor 2 (Ror2) and LDL recep-
tor-related protein 5 (Lrp5) (Fig. 3(a)). In the ileum, WPI
increased the mRNA expression of Wnt5a and caused a
trend towards an increase in the gene expression of Fzd4
(P¼0·094; Fig. 3(c)). In the duodenum, the Wnt signalling-
associated genes did not respond to the WPI treatment
(Fig. 3(b)). However, in the same region, WPI intake caused
a trend towards a decrease in the gene expression of insulin
receptor (IR) and Na–glucose co-transporter 1 (SGLT-1),
with no change in the expression of insulin receptor substrate
1 (IRS-1), GLUT2 orglucose-dependent insulinotrophic peptide
(GIP) (Table 2). WPI intake decreased the gene expression of
cholecystokinin (CCK), but not significantly (Table 2). In the
ileum, WPI intake increased the gene expression of GLUT2,
but decreased the expression of fatty acid transporter protein
4 (FATP4) (Table 2). The expression of proglucagon in the
ileum was unaffected by WPI intake (Table 2), which corre-
lated with plasma GLP-1 levels (Table 3); however, WPI
reduced the gene expression of peptide YY (PYY) (Table 2).
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Fig. 1. Effect of whey protein isolate on energy balance-related parameters.
Mice were fed a diet containing either 10 % energy from fat and 35 % energy
from sucrose with 20 % energy from casein (LF-CAS) or 10 % energy from
fat and 35 % energy from sucrose with 20 % energy from whey protein isolate
(LF-WPI) for 15 weeks. (a) Body-weight trajectories over the period of
15 weeks are shown ( , LF-CAS; , LF-WPI), together with (b) weight
gain, (c) body composition and (d) cumulative energy intake over the first
13 weeks. , LF-CAS; , LF-WPI. Values are means (n 8), with their
standard errors represented by vertical bars. Mean value was significantly
different from that of the LF-CAS group: *P,0·05, **P,0·01.
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Fig. 2. Effect of whey protein isolate on (a) tissue weight and (b) small-intes-
tinal length. Mice fed a diet containing either 10 % energy from fat and 35 %
energy from sucrose with 20 % energy from casein ( , LF-CAS) or 10 %
energy from fat and 35 % energy from sucrose with 20 % energy from whey
protein isolate ( , LF-WPI) for 15 weeks. Tissue weight is shown relative to
casein. Values are means (n 8), with their standard errors represented by
vertical bars. Mean value was significantly different from that of the LF-CAS
group: *P,0·05, **P,0·01, ***P,0·001. SAT, subcutaneous white adipose
tissue; EAT, epididymal white adipose tissue.
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Investigation of the same tissues in a previous published
study conducted in mice fed a similar LF-CAS and LF-WPI
diet for 7 weeks(5) revealed that while the stomach weight
was not different between the two groups (1·06 (SE 0·10) for
the LF-WPI group v. 1·00 (SE 0·048) for the LF-CAS group;
data are shown relative to the LF-CAS group, which is set at
1·00), the intestinal weight was reduced in the LF-WPI group
relative to the LF-CAS group (0·73 (SE 0·026) for the LF-WPI
group v. 1·00 (SE 0·035) for the LF-CAS group; P,0·001;
data are shown relative to the LF-CAS group, which is set
at 1·00), as was the intestinal length (33·65 (SE 0·38) cm for
the LF-WPI group v. 35·64 (SE 0·70) cm for the LF-CAS
group; P,0·05).
Effect of whey protein isolate on plasma hormones and
metabolites and lipid metabolic-related gene expression
Although WPI intake did not affect plasma leptin (Table 3)
and related epididymal gene expression levels (Fig. 4), or
plasma levels of TAG, insulin and glucose (Table 3), epididy-
mal expression levels of fatty acid synthase (FASN), acetyl-CoA
carboxylase (ACC) and cluster of differentiation 36 (CD36)
were significantly up-regulated in the LF-WPI group compared
with the LF-CAS group at week 15 (Fig. 4). Additionally, there
was a trend towards an increase in the gene expression of
lipoprotein lipase (P¼0·08; Fig. 4). The genes involved
in insulin signalling (IR, GLUT4 and IRS-1), fatty acid cata-
bolism (b3-adrenergic receptor (b3-AR), hormone-sensitive
lipase (HSL), carnitine palmitoyltransferase 1b (CPT1b) and
uncoupling protein 2 (UCP-2)) and adipogenesis (PPARg)
were unaltered by WPI intake (Fig. 4). None of the insulin
signalling or lipid metabolism-related genes was altered by
WPI intake in the muscle or liver (see online Supplementary
Tables S3 and S4), with the exception of IRS-1, which
showed a trend towards a decrease in expression in the
muscle of the LF-WPI group compared with the LF-CAS
group (see online Supplementary Table S3).
Discussion
The results from the present study showed that intake of
WPI for 15 weeks decreased weight gain, cumulative energy
intake and dark-phase metabolic activity (VO2), which was
accompanied by a reduction in stomach weight and intestinal
length and weight in mice fed a low-fat diet. WPI-fed mice
exhibited reduced cumulative energy intake by week 11.
Dark-phase metabolic activity, measured at week 14, also
decreased in the LF-WPI group compared with the LF-CAS
group. The reduced body-weight gain with WPI intake
could thus be a consequence of the gradual decrease in
cumulative energy intake occurring before the change in the
metabolic rate. Intestinal satiation/satiety-related CCK and
proglucagon genes were unresponsive to the intake of
WPI, as was plasma GLP-1 levels. Moreover, ileal expression
of PYY, which reduces energy intake(11), was significantly
decreased in the LF-WPI group compared with the LF-CAS
group. These data suggest that modulation of the production
of these satiety and satiation hormones was not the mechan-
ism by which WPI reduces cumulative energy intake.
The present data show that WPI intake reduces intestinal
length. Given the association between the reduction in intes-
tinal length and weight loss(12), herein, we sought to obtain
further evidence supporting a link between WPI-induced
changes in intestinal cellular activity and energy balance in
mice by investigating nutrient-responsive genes in the duod-
enum and ileum. Consistent with a reduced nutrient contact
with or passage through the intestinal cells, duodenal
gene expression of IR and SGLT-1, which is responsive to
glucose(13), showed a decreased trend in the LF-WPI group
compared with the LF-CAS group. In the ileum, the cellular
lipid transport protein FATP4 (14) and PYY, which are mainly
responsive to the availability of fat(15), were both significantly
decreased by WPI intake. Although duodenal mRNA expre-
ssion of GLUT2, the protein product of which is predominantly
found at the basolateral membrane of enterocytes(16), was
Table 1. Metabolic parameters in mice fed a diet containing either 10 % energy from fat and
35 % energy from sucrose with 20 % energy from casein (LF-CAS) or 10 % energy from
fat and 35 % energy from sucrose with 20 % energy from whey protein isolate (LF-WPI)
at week 14
(Mean values with their standard errors)
LF-CAS (n 8) LF-WPI (n 8)
Phase Mean SE Mean SE P
Energy intake (kJ/mouse) Light 12·17 1·46 10·40 2·42 NS
Dark 43·06 2·10 32·86 3·91 NS
Meal number Light 13·0 1·1 20·3 5·0 NS
Dark 31·9 2·9 25·4 3·0 NS
Meal size (kJ) Light 0·99 0·16 0·80 0·12 NS
Dark 1·46 0·20 1·15 0·19 NS
Water intake (ml/mouse) Light 0·61 0·10 0·82 0·22 NS
Dark 2·83 0·32 3·65 0·69 NS
VO2 (ml/h) Light 91·8 2·58 84·94 2·58 0·097
Dark 104·83 1·54 98·74 1·54 ,0·05
RER (VCO2/VO2) Light 0·83 0·01 0·82 0·03 NS
Dark 0·98 0·01 0·92 0·02 NS
VCO2, CO2 production.
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increased by WPI intake, one could argue based on other
nutrient-responsive genes that this change may represent a
feedback mechanism to the lower availability of nutrients in
the luminal side of the intestine. The intestinal gene
expression data are consistent with the changes in cumulative
energy intake in mice.
To ascertain the time frame of the changes in intestinal
length and weight relative to energy intake, we investigated
the same tissues in an earlier published study conducted in
mice fed the same LF-CAS and LF-WPI diets, but the study
was terminated at week 7(5). In that study, by week 7, mice
fed with WPI consumed a similar energy content to their
casein-fed counterparts, and had reduced intestinal weights
and lengths similar to those observed in the present study.
Therefore, this suggests that the reduction in cumulative
energy intake, which reached significance compared with
casein-fed mice by week 11, occurred after the morphological
change in the intestine. It is noteworthy that obese (ob/ob)
mice have longer intestines(17) and that the development of
high-fat diet-induced obesity in mice also increases villus
length and cells per villus(18). Moreover, a recent study has
shown that WPI intake reduced growth-related parameters
within the first week of dietary intake(19). The data from the
present study also show that WPI intake reduced stomach
weight in mice. In contrast, in our previous published study
conducted for 7 weeks, mice fed with WPI had an unaltered
stomach weight, suggesting that the reduction in stomach
weight occurred between 7 and 15 weeks of WPI intake,
after the reduction in intestinal length. Together, these data
suggest a potential functional relationship between WPI-
induced changes in the gastrointestinal tract and energy intake.
Organ development is in part regulated by the Wnt/b-catenin
pathway involving Wnt proteins, Fzd and Lrp-5/6 receptor
complexes, which interact and mediate the effects through
b-catenin proteins(20). Notably, Wnt5a has been shown to
act independently of the b-catenin pathway (non-canonical
signalling); however, recent data suggest that it can also inhibit
and stimulate the canonical Wnt/b-catenin pathway by acting
through the Ror2 receptor, which has been revealed by the
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Fig. 3. Effect of whey protein isolate on the gene expression of gastrointestinal
Wnt signalling. Mice were fed a diet containing either 10 % energy from fat
and 35 % energy from sucrose with 20 % energy from casein ( , LF-CAS) or
10 % energy from fat and 35 % energy from sucrose with 20 % energy from
whey protein isolate ( , LF-WPI) for 15 weeks. mRNA expression levels were
measured in the (a) stomach, (b) duodenum and (c) ileum. Gene expression is
shown relative to the LF-CAS group, which was set at 1·00. Values are means
(n 6–8), with their standard errors represented by vertical bars. Mean value
was significantly different from that of the LF-CAS group: **P,0·01. Wnt5a,
Wingless/int-1 5a; Ror2, receptor tyrosine kinase-like orphan receptor 2;
Fzd4, frizzled 4; Lrp5, LDL receptor-related protein 5.
Table 2. Intestinal gene expression in mice fed a diet containing either
10 % energy from fat and 35 % energy from sucrose with 20 % energy
from casein (LF-CAS) or 10 % energy from fat and 35 % energy from
sucrose with 20 % energy from whey protein isolate (LF-WPI) for
15 weeks*
(Mean values with their standard errors)
LF-CAS (n 6–8) LF-WPI (n 6–8)
Mean SE Mean SE P†
Duodenum
IR 1·00 0·12 0·68 0·09 0·05
GLUT2 1·00 0·09 0·94 0·06 NS
IRS-1 1·00 0·09 0·84 0·07 NS
SGLT-1 1·00 0·07 0·83 0·05 0·07
CCK 1·00 0·05 0·76 0·15 NS
GIP 1·00 0·10 0·65 0·15 NS
FATP4 1·00 0·06 1·13 0·13 NS
Ileum
IR 1·00 0·04 1·00 0·07 NS
GLUT2 1·00 0·21 1·89 0·31 ,0·05
IRS-1 1·00 0·06 1·13 0·17 NS
SGLT-1 1·00 0·09 0·99 0·10 NS
Proglucagon 1·00 0·07 1·13 0·17 NS
PYY 1·00 0·11 0·60 0·06 ,0·01
FATP4 1·00 0·08 0·77 0·04 ,0·05
IR, insulin receptor; IRS-1, insulin receptor substrate 1; SGLT-1, Na–glucose
co-transporter 1; CCK, cholecystokinin; GIP, glucose-dependent insulinotrophic
peptide; FATP4, fatty acid transporter protein 4; PYY, peptide YY.
* Gene expression is shown relative to the LF-CAS group, which was set at 1·00.
† Values differed significantly at P,0·05.
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generation of transgenic mice overexpressing Wnt5a (21) and
by the overexpression of Fzd4 and Lrp5 in 293 cells, where
experimental manipulation allowed Wnt5a to stimulate
Wnt/b-catenin signalling pathway(22). Notably, mice ectopically
expressing Wnt5a were stillborn and had reduced stomach and
intestinal tracts(21). Interestingly, targeted deletion of the Wnt5a
gene in mice also caused changes in the gastrointestinal tract(23)
similar to mice overexpressing the same gene(21). Contrasting
genetic manipulations of Wnt5a resulting in similar gastrointes-
tinal features in mice suggest a complex interplay between
the non-canonical Wnt5a signalling pathway and the Wnt/
b-catenin pathway. This complexity is further highlighted in
the present study, as the gene expression of Wnt5a and Fzd4
decreased in the stomach of the LF-WPI group compared
with the LF-CAS group, while the same genes in the ileum
responded to the protein intake by increasing their expression,
yet the two tissues reduced in weight. In contrast, neither gene
was affected by WPI in the duodenum, with Ror2 and Lrp5
remaining unchanged throughout the gastrointestinal tract
where their gene expression was investigated. Importantly,
the present study demonstrates that Wnt signalling-associated
genes in the gastrointestinal tract are responsive to WPI. We
speculate that the regional-specific expression and actions of
Wnt5a and Fzd4 and associated inhibitory or stimulatory effects
on the Wnt/b-catenin signalling pathway underlie the observed
changes in the gastrointestinal tract of WPI-fed mice, which, in
turn, modulate energy intake and body-weight gain.
Although whey protein intake has been shown to cause an
insulinotropic effect(24,25), in the present study, WPI did not
alter plasma levels of insulin, glucose or GLP-1, intestinal
expression of GIP, or insulin signalling-associated genes in
the liver, muscle or epididymal tissues. The lack of an insuli-
notropic effect could be due to the reduction in cumulative
energy intake and associated reduced nutrient availability
and/or due to the high sucrose content in the diet, which
has previously been shown to cause glucose intolerance and
impair GLP-1 secretion in mice(26). Notably, there was a
trend towards a decrease in the expression of IR in the duode-
num in response to WPI intake. It remains to be determined
whether this was related to the altered intestinal morphology
because insulin action in the intestine has been shown to
promote greater enterocyte turnover, which correlates with
the expression of IR in the villus–crypt axis(27).
In the present study, there was a mismatch in the time frame
of decreased cumulative energy intake and body-weight gain
as the former decreased by week 11, while body-weight gain
was significantly different by week 12. Even at the end of the
study, the plasma TAG level was not different between the
two groups of mice, nor was the percentage of fat content
in the body or specifically in the epididymal and subcu-
taneous fat pads. In this respect, it is noteworthy that the
epididymal expression of lipogenic ACC and FASN increased
in association with a concurrent increased expression of the
fatty acid transporter CD36(28). These data suggest increased
lipogenesis in the epididymal adipose tissue, which may
play a role in maintaining energy homeostasis causing a mis-
match in the time frame between decreased cumulative
energy intake and body weight. In line with this suggestion,
metabolic activity, measured at week 14, also decreased by
WPI intake, presumably because of decreasing cumulative
energy in mice with an altered gastrointestinal tract. In
Table 3. Plasma parameters in mice fed a diet containing either 10 %
energy from fat and 35 % energy from sucrose with 20 % energy from
casein (LF-CAS) or 10 % energy from fat and 35 % energy from sucrose
with 20 % energy from whey protein isolate (LF-WPI) for 15 weeks
(Mean values with their standard errors)
LF-CAS (n 8) LF-WPI (n 8)
Mean SE Mean SE P
Plasma TAG (mmol/l) 0·41 0·02 0·38 0·03 NS
Plasma leptin (ng/ml) 6·65 1·53 5·80 1·38 NS
Plasma GLP-1 (pM) 24·70 3·50 23·59 1·50 NS
Plasma glucose (mmol/l) 12·18 1·57 13·11 0·84 NS
Plasma insulin (ng/ml) 0·21 0·01 0·22 0·01 NS
HOMA-IR 3·07 0·39 3·12 0·16 NS
GLP-1, glucagon-like peptide 1; HOMA-IR, homeostasis model assessment of
insulin resistance.
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Fig. 4. Effect of whey protein isolate on the expression of epididymal adipose tissue genes. Mice were fed a diet containing either 10 % energy from fat and
35 % energy from sucrose with 20 % energy from casein ( , LF-CAS) or 10 % energy from fat and 35 % energy from sucrose with 20 % energy from whey protein
isolate ( , LF-WPI) for 15 weeks. The expression levels of epididymal adipose tissue genes were measured. Gene expression is shown relative to the LF-CAS
group, which was set at 1·00. The genes investigated were insulin receptor (IR), GLUT4, insulin receptor substrate 1 (IRS-1), b3-adrenergic receptor (b3-AR),
hormone-sensitive lipase (HSL), carnitine palmitoyltransferase 1b, (CPT1b), uncoupling protein 2 (UCP-2), PPARg, lipoprotein lipase (LPL), fatty acid transporter
protein 1 (FATP1), cluster of differentiation 36 (CD36), fatty acid synthase (FASN), acetyl-CoA carboxylase (ACC) and leptin. Values are means (n 8), with their
standard errors represented by vertical bars. Mean value was significantly different from that of the LF-CAS group: *P,0·05, **P,0·01.
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contrast, in our previous published studies, WPI at 20 %
energy content in a diet with 45 % energy from fat reduced
fat mass and normalised energy intake without affecting
metabolic activity in mice at 8 and 21 weeks compared with
the casein-fed control(4,5). In the latter studies, data for
metabolic activity were shown relative to body weight (ml/h
per kg). In light of the suggestion that ANCOVA is a more
suitable statistical method to identify the effects of the diet
on metabolic activity independent of body-weight changes,
we reanalysed these previously published data using
ANCOVA(10). Again, as with our previously published VO2
data (in ml/h per kg)(4), there was no significant effect of
WPI on VO2 (ml/h) independent of the body weight in mice
fed a high-fat diet with WPI (data not shown). Thus, the
contrasting effects of WPI on energy intake, fat mass and
metabolic activity in the previously published studies(4,5)
compared with the present study could be related to how
whey proteins affect energy balance in a background of
altered fat to carbohydrate content in the diet.
In conclusion, the results herein show that 20 % energy from
WPI in a diet containing 10 % energy from fat and 35 % energy
from sucrose reduced cumulative energy intake, dark-phase
metabolic activity and body-weight gain. This is accompanied
by a decreased intestinal length and weight, as well as stomach
weight, which was correlated with an altered expression
of Wnt signalling-associated genes. Further investigations are
required to determine the significance of the alteration to
the intestinal environment uncovered herein for the regulation
of energy balance.
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